Subtype
Benign Lymphatic Vessel Neoplasm
CI-CAN-00001908Explore in graph →
Non-malignant4 active trials
- NCIt
- C6524
Loading cancer entity…
Subtype
CI-CAN-00001908Explore in graph →
Clinical trials
11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05983159 | A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations(TARGET-VM) | recruiting | Phase 2 | 50 | Murdoch Childrens Research InstituteOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT06239480 | SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations(SELVA) | active not recruiting | Phase 3 | 51 | Palvella Therapeutics, Inc.INDUSTRY | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07477548 | A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies | not yet recruiting | Phase 2 | 67 | Yonsei UniversityOTHER | 0 | Mar 17, 2026 | clinicaltrials |
Data updated 22 days agoSource updated May 5, 2026source: clinicaltrials
| NCT00975819 |
| Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies |
| completed |
| Phase 2 |
| 61 |
| Denise Martin AdamsOTHER |
| 1 |
| Jan 6, 2026 |
| clinicaltrials |
| NCT06943703 | Bleomycin as an Effective and Curative Adjunct Therapy for Lymphangioma | completed | — | 809 | National Children's Hospital, VietnamOTHER | 1 | Apr 24, 2025 | clinicaltrials |
| NCT06892964 | Institution of an Italian Registry and Biobank for Biological Sample Collection(IReg-LM) | recruiting | N/A | 70 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 25, 2025 | clinicaltrials |
| NCT05050149 | Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations | completed | Phase 2 | 12 | Palvella Therapeutics, Inc.INDUSTRY | 1 | Jan 17, 2025 | clinicaltrials |
| NCT06257719 | Clinical Characteristics of Lymphatic Malformations | completed | — | 320 | West China HospitalOTHER | 1 | Feb 14, 2024 | clinicaltrials |
| NCT03941782 | Compassionate Use of BYL 719 Alpelisib | no longer available | — | — | New Mexico Cancer Research AllianceOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT06160739 | Role of Sirolimus in Treatment of Microcystic , Mixed Lymphatic and Vascular Malformations | unknown | — | 10 | Sohag UniversityOTHER | 1 | Dec 15, 2023 | clinicaltrials |
| NCT01290484 | A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations | completed | Phase 1 / Phase 2 | 7 | Stanford UniversityOTHER | 1 | Jun 19, 2015 | clinicaltrials |